Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1905 1
1910 1
1923 1
1928 1
1934 1
1935 1
1939 1
1940 1
1944 1
1946 1
1947 1
1948 4
1949 1
1950 3
1951 2
1952 3
1953 8
1954 15
1955 12
1956 12
1957 21
1958 13
1959 16
1960 17
1961 26
1962 26
1963 70
1964 122
1965 101
1966 99
1967 141
1968 201
1969 180
1970 172
1971 159
1972 223
1973 265
1974 272
1975 337
1976 310
1977 326
1978 270
1979 365
1980 362
1981 391
1982 376
1983 491
1984 575
1985 614
1986 539
1987 504
1988 499
1989 509
1990 516
1991 519
1992 527
1993 487
1994 564
1995 593
1996 533
1997 503
1998 578
1999 611
2000 654
2001 610
2002 685
2003 670
2004 643
2005 610
2006 740
2007 748
2008 794
2009 789
2010 752
2011 843
2012 852
2013 847
2014 841
2015 837
2016 763
2017 734
2018 807
2019 750
2020 875
2021 943
2022 865
2023 843
2024 273

Text availability

Article attribute

Article type

Publication date

Search Results

30,879 results

Results by year

Filters applied: . Clear all
Page 1
Factor VIII: structure and function in blood clotting.
Chavin SI. Chavin SI. Am J Hematol. 1984 Apr;16(3):297-306. doi: 10.1002/ajh.2830160312. Am J Hematol. 1984. PMID: 6424437 Review.
Factors IXa and VIII and X appear to form a functional complex, all of which need to be present and active simultaneously for optimal activation of factor X. ...Factors IXa and Xa also have been reported to activate factor VIII. ...
Factors IXa and VIII and X appear to form a functional complex, all of which need to be present and active simultaneously for …
Factor VIII inhibitors: risk factors and methods for prevention and immune modulation.
Zhang AH, Skupsky J, Scott DW. Zhang AH, et al. Clin Rev Allergy Immunol. 2009 Oct;37(2):114-24. doi: 10.1007/s12016-009-8122-5. Clin Rev Allergy Immunol. 2009. PMID: 19199081 Review.
Patients with hemophilia A are deficient in coagulation Factor VIII. This bleeding disorder can be treated with Factor VIII replacement therapy, but close to a third of patients will be immunized to the treatment and begin to form inhibitory antibodies …
Patients with hemophilia A are deficient in coagulation Factor VIII. This bleeding disorder can be treated with Factor …
The factor VIII complex: structure and function.
Hoyer LW. Hoyer LW. Blood. 1981 Jul;58(1):1-13. Blood. 1981. PMID: 6165414 Free article. Review.
Normal human plasma contains a complex of two proteins that are important in hemostasis and coagulation. The factor VIII procoagulant protein (antihemophilic factor) and the factor VIII-related protein (von Willebrand factor) are under se …
Normal human plasma contains a complex of two proteins that are important in hemostasis and coagulation. The factor VIII proco …
Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII.
Schulte S. Schulte S. Thromb Res. 2013 Mar;131 Suppl 2:S2-6. doi: 10.1016/S0049-3848(13)70150-6. Thromb Res. 2013. PMID: 23537723 Review.
Albumin fusion technology has been used to enhance the pharmacokinetic properties of recombinant coagulation factors. The goal of linking albumin to coagulation factors is to extend the half-life of the coagulation factor, thereby allowing for less frequent d …
Albumin fusion technology has been used to enhance the pharmacokinetic properties of recombinant coagulation factors. The goal of lin …
Management of factor VIII inhibitors: evolution and current status.
Bloom AL. Bloom AL. Haemostasis. 1992;22(5):268-75. doi: 10.1159/000216334. Haemostasis. 1992. PMID: 1478538 Review.
Management of patients with factor VIII (and IX) inhibitors includes management of acute bleeds and methods to induce immune suppression and tolerance and to detect patients at risk of developing inhibitors. The methods used over the years to treat acute bleeding ha …
Management of patients with factor VIII (and IX) inhibitors includes management of acute bleeds and methods to induce immune s …
The factor VIII complex: structure and function.
Hoyer LW. Hoyer LW. Prog Clin Biol Res. 1981;72:1-26. Prog Clin Biol Res. 1981. PMID: 6801681 Review.
Normal human plasma contains a complex of two proteins that are important in hemostasis and coagulation. The factor VIII procoagulant protein (antihemophilic factor) and the factor VIII-related protein (von Willebrand factor) are under se …
Normal human plasma contains a complex of two proteins that are important in hemostasis and coagulation. The factor VIII proco …
[Factor VIII and the risk of arterial thrombosis].
Małecki R, Adamiec R. Małecki R, et al. Postepy Hig Med Dosw (Online). 2006;60:602-8. Postepy Hig Med Dosw (Online). 2006. PMID: 17199101 Review. Polish.
From among a few clotting factors (V, VIII, XIII), factor VIII arouses interest due to the well-known observation that the morbidity for cardiovascular reasons is less among hemophiliacs than in the general population. ...A high factor VIII …
From among a few clotting factors (V, VIII, XIII), factor VIII arouses interest due to the well-known observatio …
A close insight to factor VIII inhibitor in the congenital hemophilia A.
Tabriznia-Tabrizi S, Gholampour M, Mansouritorghabeh H. Tabriznia-Tabrizi S, et al. Expert Rev Hematol. 2016 Sep;9(9):903-13. doi: 10.1080/17474086.2016.1208554. Epub 2016 Aug 16. Expert Rev Hematol. 2016. PMID: 27367203 Review.
HA is caused by a decreased or deficiency of the functional clotting factor VIII (FVIII) and effects 1 in 5000-10,000 male births. The common treatment for hemophilia is replacement therapy by plasma-derived or recombinant FVIII. ...AREAS COVERED: A literature revie …
HA is caused by a decreased or deficiency of the functional clotting factor VIII (FVIII) and effects 1 in 5000-10,000 male bir …
Factor VIII/von Willebrand factor.
Zimmerman TS, Ruggeri ZM, Fulcher CA. Zimmerman TS, et al. Prog Hematol. 1983;13:279-309. Prog Hematol. 1983. PMID: 6422506 Review. No abstract available.
30,879 results
You have reached the last available page of results. Please see the User Guide for more information.